2022
https://www.sciencedirect.com/science/article/abs/pii/S1044579X20302029
Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural
Rapid progress in molecular cancer biology coupled with the discovery of novel oncology drugs has opened new horizons for cancer target discovery. As …
www.sciencedirect.com
Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds
'전사인자' 카테고리의 다른 글
| (레스베라트롤)은 인간 혀 편평 세포 암종 및 간암 세포에서 HIF 1A 및 VEGF 발현의 저산소증 유도 축적을 억제 (0) | 2022.10.01 |
|---|---|
| 알벤다졸에 의한 종양성 HIF 1α의 강력한 억제 (0) | 2022.10.01 |
| ⚡주요 유전자 신호 (0) | 2021.11.12 |
| 천연 화합물의 후성 유전적 활성(HDAC Inhibitors) (0) | 2021.11.09 |
| 암세포의 NRF2 중독 (0) | 2021.10.20 |